- Home
- HII vs BMRN Comparison
HII vs BMRN Comparison
Compare HII & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HII
- BMRN
- Stock Information
- Founded
- HII 1886
- BMRN 1996
- Country
- HII United States
- BMRN United States
- Employees
- HII N/A
- BMRN N/A
- Industry
- HII Marine Transportation
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HII Industrials
- BMRN Health Care
- Exchange
- HII Nasdaq
- BMRN Nasdaq
- Market Cap
- HII 10.0B
- BMRN 11.3B
- IPO Year
- HII N/A
- BMRN 1999
- Fundamental
- Price
- HII $278.70
- BMRN $57.85
- Analyst Decision
- HII Hold
- BMRN Buy
- Analyst Count
- HII 9
- BMRN 23
- Target Price
- HII $244.50
- BMRN $93.73
- AVG Volume (30 Days)
- HII 487.0K
- BMRN 1.7M
- Earning Date
- HII 07-31-2025
- BMRN 08-04-2025
- Dividend Yield
- HII 1.94%
- BMRN N/A
- EPS Growth
- HII N/A
- BMRN 152.82
- EPS
- HII 13.36
- BMRN 2.71
- Revenue
- HII $11,569,000,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- HII $4.38
- BMRN $12.27
- Revenue Next Year
- HII $4.48
- BMRN $9.99
- P/E Ratio
- HII $20.87
- BMRN $21.40
- Revenue Growth
- HII N/A
- BMRN 19.36
- 52 Week Low
- HII $158.88
- BMRN $52.93
- 52 Week High
- HII $292.50
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- HII 73.95
- BMRN 49.59
- Support Level
- HII $256.45
- BMRN $57.58
- Resistance Level
- HII $268.00
- BMRN $59.62
- Average True Range (ATR)
- HII 5.67
- BMRN 1.46
- MACD
- HII 0.59
- BMRN -0.01
- Stochastic Oscillator
- HII 65.98
- BMRN 34.68
About HII Huntington Ingalls Industries Inc.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out of Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia and Columbia-class nuclear submarines. Huntington Ingalls shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's Mission Technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.